54 related articles for article (PubMed ID: 1190929)
21. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
22. The pathologist's role in the diagnosis and therapy of rectal cancer.
Vecchio FM
Rays; 1995; 20(1):15-20. PubMed ID: 7569064
[TBL] [Abstract][Full Text] [Related]
23. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point.
Guillem JG; Chessin DB; Shia J; Moore HG; Mazumdar M; Bernard B; Paty PB; Saltz L; Minsky BD; Weiser MR; Temple LK; Cohen AM; Wong WD
J Clin Oncol; 2005 May; 23(15):3475-9. PubMed ID: 15908656
[TBL] [Abstract][Full Text] [Related]
24. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
25. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
26. [Cancer of the middle third of the rectum].
Farthmann EH; Fiedler L
Z Gastroenterol; 1987 Apr; 25(4):233-40. PubMed ID: 3590901
[TBL] [Abstract][Full Text] [Related]
27. [Long-term follow-up of patients treated with radical surgery for rectal cancer].
Szentpétery F; Atkári B; Jakab F
Magy Onkol; 2008 Mar; 52(1):57-63. PubMed ID: 18403298
[TBL] [Abstract][Full Text] [Related]
28. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation.
Minagawa M; Yamamoto J; Kosuge T; Matsuyama Y; Miyagawa S; Makuuchi M
Arch Surg; 2007 Mar; 142(3):269-76; discussion 277. PubMed ID: 17372052
[TBL] [Abstract][Full Text] [Related]
29. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
Greene FL; Stewart AK; Norton HJ
J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
[TBL] [Abstract][Full Text] [Related]
30. A method of clinical prognostic staging for patients with rectal cancer.
Zorzitto M; Germanson T; Cummings B; Boyd NF
Dis Colon Rectum; 1982; 25(8):759-65. PubMed ID: 7172943
[TBL] [Abstract][Full Text] [Related]
31. A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer.
Clemens JD; Feinstein AR; Holabird N; Cartwright S
J Chronic Dis; 1986; 39(11):913-28. PubMed ID: 3793842
[TBL] [Abstract][Full Text] [Related]
32. Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?
Yamamoto N; Yamamoto R; Ariumi Y; Mizokami M; Shimotohno K; Yoshikura H
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066804
[TBL] [Abstract][Full Text] [Related]
33. Development of a New Clinical Severity Staging System for Patients With Nonmetastatic Papillary Thyroid Carcinoma.
Karadaghy OA; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Dec; 143(12):1173-1180. PubMed ID: 28449113
[TBL] [Abstract][Full Text] [Related]
34. Radiation treatment for rectal cancer.
Cummings BJ
World J Surg; 1995; 19(2):275-81. PubMed ID: 7754635
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology.
Quirke P; Dyson JE; Dixon MF; Bird CC; Joslin CA
Br J Cancer; 1985 Jan; 51(1):99-106. PubMed ID: 2578283
[TBL] [Abstract][Full Text] [Related]
36. A reappraisal of staging and therapy for patients with cancer of the rectum. I. Development of two new systems of staging.
Feinstein AR; Schimpff CR; Hull EW
Arch Intern Med; 1975 Nov; 135(11):1441-53. PubMed ID: 1190929
[TBL] [Abstract][Full Text] [Related]
37. A reappraisal of staging and therapy for patients with cancer of the rectum. II. Patterns of presentation and outcome of treatment.
Feinstein AR; Schimpff CR; Hull EW
Arch Intern Med; 1975 Nov; 135(11):1454-62. PubMed ID: 1190930
[TBL] [Abstract][Full Text] [Related]
38. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.
Gosens MJ; van Krieken JH; Marijnen CA; Meershoek-Klein Kranenbarg E; Putter H; Rutten HJ; Bujko K; van de Velde CJ; Nagtegaal ID;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):997-1003. PubMed ID: 17544876
[TBL] [Abstract][Full Text] [Related]
39. Preservation of the continence function after intersphincteric resection using a prolapsing technique in the patients with low rectal cancer and its clinical prognosis.
Dai Y; Jiang JB; Bi DS; Jin ZT; Sun JZ; Hu SY
Chin Med J (Engl); 2008 Oct; 121(20):2016-20. PubMed ID: 19080267
[TBL] [Abstract][Full Text] [Related]
40. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
